Univariate analysis
. | N . | DFS at 18 mo (%) . | P . | Relapse at 18 mo (%) . | P . | NRM at 18 mo (%) . | P . |
|---|---|---|---|---|---|---|---|
| Patient age, y | * | — | — | ||||
| 60 or older | 10 | 30.0 | 30.0 | 40.0 | |||
| 50 to 59 | 15 | 40.0 | 40.0 | 20.0 | |||
| Younger than 50 | 17 | 35.3 | 47.1 | 17.6 | |||
| MDS | 21 | 42.9 | 28.6 | 28.6 | |||
| AML | 12 | 22.2 | .20 | 52.8 | .18 | 25.0 | — |
| CMML | 5 | 60.0 | 40.0 | 0.0 | |||
| CML | 4 | 0.0 | 75.0 | 25.0 | |||
| IPSS | .02 | .07 | .17 | ||||
| 0.5 to 1.0 | 7 | 71.4 | 14.3 | 14.3 | |||
| more than 1 and AML† | 26 | 26.0 | 43.3 | 30.8 | |||
| Patient | .08 | .05 | — | ||||
| CMV negative | 20 | 48.9 | 26.1 | 25.0 | |||
| CMV positive | 22 | 22.7 | 54.5 | 22.7 | |||
| Donor | — | .12 | — | ||||
| Related | 16 | 25.0 | 56.2 | 18.8 | |||
| Unrelated | 26 | 41.5 | 31.5 | 26.9 | |||
| Unrelated matched | 15 | 40.0 | — | 26.7 | — | 33.3 | — |
| Unrelated mismatched | 11 | 43.6 | — | 38.2 | — | 18.2 | — |
. | N . | DFS at 18 mo (%) . | P . | Relapse at 18 mo (%) . | P . | NRM at 18 mo (%) . | P . |
|---|---|---|---|---|---|---|---|
| Patient age, y | * | — | — | ||||
| 60 or older | 10 | 30.0 | 30.0 | 40.0 | |||
| 50 to 59 | 15 | 40.0 | 40.0 | 20.0 | |||
| Younger than 50 | 17 | 35.3 | 47.1 | 17.6 | |||
| MDS | 21 | 42.9 | 28.6 | 28.6 | |||
| AML | 12 | 22.2 | .20 | 52.8 | .18 | 25.0 | — |
| CMML | 5 | 60.0 | 40.0 | 0.0 | |||
| CML | 4 | 0.0 | 75.0 | 25.0 | |||
| IPSS | .02 | .07 | .17 | ||||
| 0.5 to 1.0 | 7 | 71.4 | 14.3 | 14.3 | |||
| more than 1 and AML† | 26 | 26.0 | 43.3 | 30.8 | |||
| Patient | .08 | .05 | — | ||||
| CMV negative | 20 | 48.9 | 26.1 | 25.0 | |||
| CMV positive | 22 | 22.7 | 54.5 | 22.7 | |||
| Donor | — | .12 | — | ||||
| Related | 16 | 25.0 | 56.2 | 18.8 | |||
| Unrelated | 26 | 41.5 | 31.5 | 26.9 | |||
| Unrelated matched | 15 | 40.0 | — | 26.7 | — | 33.3 | — |
| Unrelated mismatched | 11 | 43.6 | — | 38.2 | — | 18.2 | — |